George Goldberger spent more than 20 years helping to build the leading cell and gene manufacturing contract development organization, PCT (now part of Hitachi as Hitachi Chemical Advanced Therapeutics Solutions). Serving as PCT s Chief Financial Officer and Business Officer and then Vice PresidOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.